Related to Arginetix Pockets $10.75M to Further R&D of Arginase Inhibitors

• BMS Gains Nissan Chemical’s Atrial Fibrillation Therapy for $40M Up Front
  
• UCB Taps Proteros for Structure-Based Drug Discovery
  
• Calcium-Signaling Pathway Regulates Inflammatory Gene Expression following Heart Attack
  
• Researchers Identify Protein for Early Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy
  
• BG Medicine, NHLBI, and Boston University Partner for Cardiovascular Biomarker Discovery
  
• Endothelial Lipase Gene Mutations Result in High Levels of HDL-C
  
• Ten Genes Associated with Changes in QT Interval
  
• Researchers Find that Crystallized Cholesterol Can Damage Cardiovascular Plaque
  
• Dyax Eliminates 60 Positions and Expects $18M in Annual Savings
  
• Beckman Coulter to Pay Clinical Data $17M for Genomic Services Division
  
• Malfunction of the Respiratory Epithelium Implicated as Cause for Allergy
  
• ImmuneRegen Allies with University of Rochester to Expand Preclinical Development of Homspera
  
• Cordex Taps BG Medicine to Advance Its Early-Stage Heart Failure Drug
  
• Merck & Co. Buys Rights to Atrial Fibrillation Therapy from Cardiome for $60M Up Front
  
• LDL-Controlling Protein Exerts Effect Extracellularly
  
• Clarient Acquires Breast Cancer Biomarker from Indiana University
  
• Bayer Pays Ardea $35M for Its Anticancer MEK Inhibitors
  
• Role of COMT Gene Mutation in Post Heart Surgery Complications Revealed
  
• Cornerstone Inks $70M Deal for Chiesi Farmaceutici’s Respiratory Distress Syndrome Drug
  
• The Medicines Company Axes Phase III Percutaneous Coronary Intervention Program